Biotech · Private company · Encintias, CA, US
Eleven Therapeutics Corp
Track this companyFree. Adds Eleven Therapeutics Corp to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorderFiscal year 2025 · $1.4MNIH RePORTER 5R42DA056254-03 · fetched Nov 12, 2026
- Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorderFiscal year 2024 · $1.6MNIH RePORTER 2R42DA056254-02 · fetched Nov 12, 2026